Wang Z - Search Results

1

Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.

Zhang J, Wang Z, Hu X, Wang B, Wang L, Yang W, Liu Y, Liu G, Di G, Hu Z, Wu J, Shao Z. Zhang J, et al. Among authors: wang l, wang z, wang b. Int J Cancer. 2015 Jan 1;136(1):204-11. doi: 10.1002/ijc.28966. Epub 2014 May 23. Int J Cancer. 2015. PMID: 24824628 Clinical Trial.

2

XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population.

Wang Z, Xu B, Lin D, Tan W, Leaw S, Hong X, Hu X. Wang Z, et al. Lung Cancer. 2008 Oct;62(1):99-104. doi: 10.1016/j.lungcan.2008.02.019. Epub 2008 Apr 9. Lung Cancer. 2008. PMID: 18400332

3

Biweekly docetaxel-containing chemotherapy may be the optimal schedule.

Yang X, Cai Y, Zhao X, Wang Z, Hong X, Shen Z, Ou Z, Li J, Hu X. Yang X, et al. Among authors: wang z. Anticancer Drugs. 2008 Apr;19(4):421-6. doi: 10.1097/CAD.0b013e3282f7f52e. Anticancer Drugs. 2008. PMID: 18454052 Clinical Trial.

4

Chloroxoquinoline in combination with epirubicin, cisplatin and 5-fluorouracil in metastatic gastric cancer.

Zhu XD, Hu XC, Zhang W, Hong XN, Guo Y, Yin JL, Wang ZH, Li J. Zhu XD, et al. Hepatogastroenterology. 2009 Mar-Apr;56(90):555-60. Hepatogastroenterology. 2009. PMID: 19579642

5

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC. Zhang J, et al. Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9. Breast Cancer Res Treat. 2010. PMID: 20143151

6

NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.

Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC. Zhang J, et al. Breast Cancer Res Treat. 2010 Oct;123(3):877-83. doi: 10.1007/s10549-010-0807-1. Epub 2010 Feb 24. Breast Cancer Res Treat. 2010. PMID: 20180012

7

Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.

Zhang J, Qiu LX, Wang ZH, Leaw SJ, Wang BY, Wang JL, Cao ZG, Gao JL, Hu XC. Zhang J, et al. Breast Cancer Res Treat. 2010 Nov;124(2):419-24. doi: 10.1007/s10549-010-0846-7. Epub 2010 Mar 19. Breast Cancer Res Treat. 2010. PMID: 20300826

8

The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects.

Qiu LX, Zhang J, Zhu XD, Zheng CL, Sun S, Wang ZH, Zhao XM, Wang JL, Wang LP, Yu H, Xue K, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Nov;124(2):475-9. doi: 10.1007/s10549-010-0858-3. Epub 2010 Mar 27. Breast Cancer Res Treat. 2010. PMID: 20349127

9

Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer.

Chen L, Gu Y, Leaw S, Wang Z, Wang P, Hu X, Chen J, Lu J, Shao Z. Chen L, et al. Among authors: wang z, wang p. BMC Cancer. 2010 Sep 7;10:479. doi: 10.1186/1471-2407-10-479. BMC Cancer. 2010. PMID: 20819231 Free PMC article.

10

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.

Zhao X, Xu X, Guo L, Ragaz J, Guo H, Wu J, Shao Z, Zhu J, Guo X, Chen J, Zhu B, Wang Z, Hu X. Zhao X, et al. Among authors: wang z. Breast Cancer Res Treat. 2010 Dec;124(3):733-43. doi: 10.1007/s10549-010-1183-6. Epub 2010 Sep 30. Breast Cancer Res Treat. 2010. PMID: 20882405 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139,308 results

Search Page

Filters